CLOZARIL National Registry (CNR)- Tel # 1-800-448-5938
The CLOZARIL National Registry was developed in response to a FDA mandate to ensure the safety of patients treated with CLOZARIL, which has potentially dangerous side effects, if not strictly monitored. The program includes dedicated 800 numbers for internal clients, consumers and health care professionals to call for information, education and patient enrollment.

Clozaril Administration Registry Enrollment (CARE) - Tel # 1-800-448-5938
The Clozaril Administration Registry Enrollment (CARE) is a secured internet application that facilitates the reporting of White Blood Cell (WBC) values and Absolute Neutrophil Counts (ANC) of patients taking brand Clozaril® (clozapine), to the Clozaril National Registry (CNR). CARE is designed to safeguard patient information, protect the patient's privacy and assist physicians and pharmacists with effective monitoring functionalities.

Since its introduction in 1990, Clozaril has only been available through a strict monitoring and distribution system in order to detect the early onset of agranulocytosis. With proper WBC/ANC monitoring and reporting, Clozaril-induced agranulocytosis can be reversible, if detected early. Prescribers and pharmacies must be registered before they can treat patients with Clozaril. CARE is designed and developed to streamline this process.

Use CARE to:

Register new/existing patients.

Report WBC/ANC information.

Monitor patients receiving Clozaril.

View History of WBC / ANC values and dosage information.

Locate CNR registered pharmacies within the United States.

View educational and informative materials.

Download registration forms.

View Links to Novartis related sites.